Long-acting HIV therapies are becoming an increasingly competitive treatment category. While efficacy remains essential, differentiation is now shifting towards factors such as dosing convenience,...
Although modern medicines have transformed HIV into a manageable long-term condition, taking medication every day can still contribute to stigma and treatment fatigue for...
Global health leaders called on donor governments to sustain support for the HIV response, and on low- and middle-income countries to continue stepping up...
Developing an intermittent treatment relieves the need for daily pills and, given that no medicine is needed at home, directly addresses the stigma that...
Adding spironolactone led to a significant 4.4‑fold reduction in HIV RNA inside cells across the body and broadly lowered activity in genes linked to...
All government agencies are mandated to establish and implement their respective HIV and AIDS workplace policies, following the issuance of a new guideline by...